Works matching IS 18696953 AND DT 2017 AND VI 8 AND IP 1

Results: 16

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 149, doi. 10.1007/s13300-016-0215-6

By:

Hadjiyianni, Irene;
Desai, Urvi;
Suzuki, Shuichi;
Ivanova, Jasmina;
Cao, Dachuang;
Kirson, Noam;
Chida, Dai;
Enloe, Caroline;
Birnbaum, Howard;
Perez-Nieves, Magaly

Publication type:

Article

Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes.

Published in:

2017

By:

Bebakar, Wan;
Chaykin, Louis;
Hersløv, Malene;
Rasmussen, Søren

Publication type:

Report

How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 9, doi. 10.1007/s13300-016-0214-7

By:

Muñoz-Garach, Araceli;
Molina-Vega, María;
Tinahones, Francisco

Publication type:

Article

Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 167, doi. 10.1007/s13300-016-0212-9

By:

Porath, Avi;
Fund, Naama;
Maor, Yasmin

Publication type:

Article

Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures.

Published in:

2017

By:

Scattolini, Valentina;
Luni, Camilla;
Zambon, Alessandro;
Galvanin, Silvia;
Gagliano, Onelia;
Ciubotaru, Catalin;
Avogaro, Angelo;
Mammano, Fabio;
Elvassore, Nicola;
Fadini, Gian

Publication type:

Erratum

Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 85, doi. 10.1007/s13300-016-0217-4

By:

Lorenzi, Maria;
Ploug, Uffe;
Langer, Jakob;
Skovgaard, Rasmus;
Zoratti, Michael;
Jansen, Jeroen

Publication type:

Article

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 101, doi. 10.1007/s13300-016-0218-3

By:

Linjawi, Sultan;
Bode, Bruce;
Chaykin, Louis;
Courrèges, Jean-Pierre;
Handelsman, Yehuda;
Lehmann, Lucine;
Mishra, Abhishek;
Simpson, Richard

Publication type:

Article

Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 129, doi. 10.1007/s13300-016-0219-2

By:

Hunt, Barnaby;
Ye, Qing;
Valentine, William;
Ashley, Donna

Publication type:

Article

Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 23, doi. 10.1007/s13300-016-0220-9

By:

Black, Cody;
Thompson, Wade;
Welch, Vivian;
McCarthy, Lisa;
Rojas-Fernandez, Carlos;
Lochnan, Heather;
Shamji, Salima;
Upshur, Ross;
Farrell, Barbara

Publication type:

Article

Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 75, doi. 10.1007/s13300-016-0221-8

By:

Al Hayek, Ayman;
Robert, Asirvatham;
Babli, Saleha;
Almonea, Khuloud;
Al Dawish, Mohamed

Publication type:

Article

Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 177, doi. 10.1007/s13300-016-0222-7

By:

Li, Feng-fei;
Jiang, Lanlan;
Fu, Liyuan;
Zhu, Hong-hong;
Zhou, Peihua;
Zhang, Danfeng;
Su, Xiao-fei;
Wu, Jin-dan;
Ye, Lei;
Ma, Jian-hua

Publication type:

Article

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 55, doi. 10.1007/s13300-016-0223-6

By:

Haak, Thomas;
Hanaire, Hélène;
Ajjan, Ramzi;
Hermanns, Norbert;
Riveline, Jean-Pierre;
Rayman, Gerry

Publication type:

Article

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 115, doi. 10.1007/s13300-016-0224-5

By:

Divino, Victoria;
DeKoven, Mitch;
Khan, Farhad;
Boye, Kristina;
Sapin, Hélène;
Norrbacka, Kirsi

Publication type:

Article

Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data.

Published in:

2017

By:

Kaku, Kohei;
Wolden, Michael;
Hyllested-Winge, Jacob;
Nørtoft, Emil

Publication type:

Report

Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 1, doi. 10.1007/s13300-017-0231-1

By:

Kreider, Kathryn

Publication type:

Article

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2017, v. 8, n. 1, p. 33, doi. 10.1007/s13300-016-0211-x

By:

Anderson, John;
Wright, Eugene;
Shaefer, Charles

Publication type:

Article